ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
150.52
-1.55 (-1.02%)
At close: Jul 11, 2025, 4:00 PM
151.75
+1.23 (0.82%)
After-hours: Jul 11, 2025, 6:44 PM EDT
ICLR Market Cap
ICLR has a market cap or net worth of $11.96 billion as of July 11, 2025. Its market cap has decreased by -54.14% in one year.
Market Cap
11.96B
Enterprise Value
15.03B
1-Year Change
-54.14%
Ranking
Category
Stock Price
$150.52
Market Cap Chart
Since October 30, 2002, ICLR's market cap has increased from $278.50M to $11.96B, an increase of 4,194.78%. That is a compound annual growth rate of 18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 11.96B | -30.92% |
| Dec 31, 2024 | 17.31B | -25.61% |
| Dec 29, 2023 | 23.27B | 46.86% |
| Dec 30, 2022 | 15.85B | -36.65% |
| Dec 31, 2021 | 25.01B | 139.26% |
| Dec 31, 2020 | 10.46B | 12.48% |
| Dec 31, 2019 | 9.30B | 33.02% |
| Dec 31, 2018 | 6.99B | 14.26% |
| Dec 29, 2017 | 6.12B | 47.97% |
| Dec 30, 2016 | 4.13B | -11.51% |
| Dec 31, 2015 | 4.67B | 48.72% |
| Dec 31, 2014 | 3.14B | 28.87% |
| Dec 31, 2013 | 2.44B | 45.97% |
| Dec 31, 2012 | 1.67B | 61.95% |
| Dec 30, 2011 | 1.03B | -20.24% |
| Dec 31, 2010 | 1.29B | 1.63% |
| Dec 31, 2009 | 1.27B | 11.99% |
| Dec 31, 2008 | 1.14B | -35.63% |
| Dec 31, 2007 | 1.76B | 66.90% |
| Dec 29, 2006 | 1.06B | 84.85% |
| Dec 30, 2005 | 571.80M | 7.64% |
| Dec 31, 2004 | 531.20M | 2.89% |
| Dec 31, 2003 | 516.30M | 62.61% |
| Dec 31, 2002 | 317.50M | 14.00% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |